2018
DOI: 10.3390/molecules23081946
|View full text |Cite
|
Sign up to set email alerts
|

Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass Spectrometry

Abstract: Necrostatins have been shown to retard necroptosis, a programmed necrotic-like cell death, which has been shown to underlie pathophysiology of various diseases. Nec-1s, a novel highly effective necrostatin, overcomes some drawbacks of former necrostatin analogues. The determination of Nec-1s in biological system, however, has not been carried out so far. Therefore, this study was undertaken to optimize and validate the HPLC-DAD-Q-TOF method for the assessment of Nec-1s levels in the plasma what is the necessit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 16 publications
1
0
0
Order By: Relevance
“…according to previous results, serum SirT1 is highly sensitive and specific to the diagnosis of NEC, which is of certain reference value for the early diagnosis of nec (3). in a rat model, the results indicated that the expression level of SIRT1 was markedly decreased in the intestine of rats with nec induced by lPS, but this effect was reversed with SirT1 activator treatment to protect the intestine by inhibiting the inflammatory response (3,4). Therefore, SIRT1 may be a novel diagnostic biomarker of NEC and serves an important role in the development of nec.…”
Section: Introductionsupporting
confidence: 67%
“…according to previous results, serum SirT1 is highly sensitive and specific to the diagnosis of NEC, which is of certain reference value for the early diagnosis of nec (3). in a rat model, the results indicated that the expression level of SIRT1 was markedly decreased in the intestine of rats with nec induced by lPS, but this effect was reversed with SirT1 activator treatment to protect the intestine by inhibiting the inflammatory response (3,4). Therefore, SIRT1 may be a novel diagnostic biomarker of NEC and serves an important role in the development of nec.…”
Section: Introductionsupporting
confidence: 67%